Felix Vet Pharmaceuticals Pvt Ltd.
chefchenfrisco.comVisual Preview
Felix Pharma ("Felix") is a Dublin based new and innovative pharmaceutical company that aims to focus on bringing cost effective, high quality bio-equivalent products for companion animals. We are dedicated to the development of Companion Animal segment. We have invested heavily in created assets – for development and manufacturing that are dedicated towards animal health. Our team of scientists has an extensive experience in developing innovative products for AH segment. Several products are under development as well as pending FDA approval. Our current product portfolio has been developed through a combination of in-house animal health R&D experts and specialized contract development labs. We have a portfolio of over 25 products at different stages of development or approval with US FDA comprising products across multiple therapeutic segments and delivery systems. Felix' management team includes seasoned industry professionals with complementary skills that enable Felix to develop a large number of drugs, generate revenue via licensing and direct sales to end customers, and pursue other growth opportunities. Our passionate team is committed to growing our business and being among the leading veterinary generic pharmaceutical companies in the country.
Why follow Felix Vet Pharmaceuticals Pvt Ltd.?
EarlyFinder highlights companies showing breakout signals across traffic, marketing activity, and revenue proxies. Create a free account to monitor performance, benchmark against peers, and export curated lists to your workflow.
Revenue & Pricing
Revenue insights
Revenue insights locked
Sign in to access estimates, confidence ratings, and revenue benchmarks.
Unlock insightsMonthly traffic trends
Website visits over the past 12 months
Website traffic locked
Sign in to view full trendlines, YoY growth, and segment performance.
Unlock insightsTop keywords
Organic opportunities driving discovery
Traffic sources
Channel mix across the latest month
Traffic sources locked
Sign in to view acquisition mix and paid vs. organic breakdowns.
Unlock insights